Eligibility criteria
Condition
Carcinoma
Sex
Females and Males
Age
20-75 years
Inclusion criteria
Show details
- Patients histologically or cytologically diagnosed with advanced malignant solid
tumors
- Patients for whom standard therapies have not been effective, or for whom there are no
suitable therapies
Exclusion criteria
Show details
- Central lung lesions involving major blood vessels
- Patients who have been treated with bevacizumab or other VEGFR inhibitor(s)